Media coverage about Core Laboratories N.V. (NYSE:CLB) has been trending somewhat positive on Friday, Alpha One Sentiment Analysis reports. The research firm, a unit of Accern, rates the sentiment of media coverage by reviewing more than twenty million news and blog sources. Alpha One ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Core Laboratories N.V. earned a media sentiment score of 0.17 on Alpha One’s scale. Alpha One also gave news headlines about the oil and gas company an impact score of 20 out of 100, indicating that recent media coverage is very unlikely to have an effect on the company’s share price in the near term.
Here are some of the headlines that may have effected Alpha One Sentiment’s analysis:
- What’s the Correlation between Halliburton Stock and Crude Oil? (finance.yahoo.com)
- Halliburton’s Valuation Compared to Its Peers (finance.yahoo.com)
- Howe & Rusling Has Trimmed Its Vulcan Matls Co (VMC) Stake; Core Laboratories LP Has 0.86 Sentiment – UtahHerald.com (utahherald.com)
- Here’s Why the Best Is Yet to Come for Core Laboratories N.V. (fool.com)
- Core Laboratories N.V. (CLB) Rating Increased to Buy at Zacks Investment Research (americanbankingnews.com)
Core Laboratories N.V. (CLB) traded up 1.91% on Friday, reaching $106.86. 584,658 shares of the company’s stock traded hands. The stock has a market cap of $4.72 billion, a price-to-earnings ratio of 70.77 and a beta of 1.51. Core Laboratories N.V. has a 52-week low of $96.30 and a 52-week high of $127.82. The company’s 50 day moving average is $106.39 and its 200-day moving average is $113.82.
Core Laboratories N.V. (NYSE:CLB) last released its earnings results on Wednesday, April 19th. The oil and gas company reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.03. The firm had revenue of $157.81 million for the quarter, compared to analysts’ expectations of $150.44 million. Core Laboratories N.V. had a net margin of 11.10% and a return on equity of 43.28%. The company’s quarterly revenue was up 2.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.37 earnings per share. Equities analysts expect that Core Laboratories N.V. will post $2.20 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, May 23rd. Shareholders of record on Friday, April 28th were paid a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date was Thursday, April 27th. Core Laboratories N.V.’s payout ratio is 145.70%.
Several equities research analysts recently issued reports on CLB shares. Loop Capital upgraded shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and raised their target price for the company from $125.00 to $130.00 in a research note on Friday, April 21st. Tudor Pickering started coverage on shares of Core Laboratories N.V. in a research note on Thursday, March 23rd. They issued a “hold” rating for the company. Scotiabank set a $133.00 target price on shares of Core Laboratories N.V. and gave the company a “hold” rating in a research note on Wednesday, March 22nd. Zacks Investment Research upgraded shares of Core Laboratories N.V. from a “hold” rating to a “buy” rating and set a $126.00 target price for the company in a research note on Friday, February 24th. Finally, Citigroup Inc. reiterated a “neutral” rating and issued a $117.00 target price (down from $119.00) on shares of Core Laboratories N.V. in a research note on Saturday, March 11th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $118.25.
COPYRIGHT VIOLATION NOTICE: This news story was published by WKRB News and is the property of of WKRB News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.wkrb13.com/markets/2229229/somewhat-positive-press-coverage-very-unlikely-to-affect-core-laboratories-n-v-clb-share-price.html.
About Core Laboratories N.V.
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229229/somewhat-positive-press-coverage-very-unlikely-to-affect-core-laboratories-n-v-clb-share-price.html
Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.